Header Logo

DAVID MOORE

TitleDistinguished Emeritus Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Molecular & Cellular Biology
AddressOne Baylor Plaza
Houston, TX 77030
vCardDownload vCard
    Other Positions
    TitleDistinguished Emeritus Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Medicine
    DivisionMedicine-Endocrinology

    TitleDistinguished Emeritus Professor
    InstitutionBaylor College of Medicine
    DepartmentDepartment of Molecular & Human Genetics
    DivisionMolecular & Human Genetics


    Collapse Affiliation 
    Collapse groups

    Collapse Research 
    Collapse research activities and funding
    R01CA238988     (FU, LONING NONE)Sep 1, 2019 - Aug 31, 2024
    NIH
    Sympathetic circadian dysfunction in obesity-related hepatocarcinogenesis
    Role: Co-Principal Investigator
    R01CA230848     (FU, LONING NONE ;MOORE, DAVID D)Sep 18, 2018 - Aug 31, 2023
    NIH
    (PQ6)Nuclear receptor mechanisms in circadian disruption induced hepatocarcinogenesis
    Role: Co-Principal Investigator
    R13DK117645     (MOORE, DAVID D)Jun 10, 2018 - Jun 9, 2019
    NIH
    FASEB SRC on Fundamental Biology and Pathophysiology of the Liver
    Role: Principal Investigator
    R01DK083572     (MOORE, DAVID D)Jul 20, 2009 - Jun 30, 2011
    NIH
    Function of the Nuclear Receptor LRH-1
    Role: Principal Investigator
    R01DK068804     (MOORE, DAVID D)Apr 1, 2005 - Mar 31, 2010
    NIH
    Functions of the Nuclear Receptor SHP
    Role: Principal Investigator
    P01DK057743     (MOORE, DAVID D)Jun 1, 2000 - May 31, 2005
    NIH
    ORPHAN RECEPTORS IN ORGANOGENESIS
    Role: Principal Investigator
    R13DK054265     (MOORE, DAVID D)Jul 22, 1998 - Jul 21, 1999
    NIH
    29TH GORDON CONFERENCE ON HORMONE ACTION
    Role: Principal Investigator
    R01DK053366     (MOORE, DAVID D)Apr 1, 1998 - Mar 31, 2007
    NIH
    Function of The Bile Acid Receptor FXR
    Role: Principal Investigator
    R01DK046546     (MOORE, DAVID D)Feb 1, 1995 - Aug 31, 2015
    NIH
    Functions of the Nuclear Receptor CAR
    Role: Principal Investigator
    T32DK007696     (MOORE, DAVID D)Sep 5, 1993 - Aug 31, 2013
    NIH
    Training Program in Molecular Endocrinology
    Role: Principal Investigator
    R01DK043382     (MOORE, DAVID D)Aug 1, 1991 - Jul 31, 2002
    NIH
    BIOCHEMISTRY AND GENETICS OF THYROID HORMONE RECEPTORS
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Wooton-Kee CR, Robertson M, Zhou Y, Dong B, Sun Z, Kim KH, Liu H, Xu Y, Putluri N, Saha P, Coarfa C, Moore DD, Nuotio-Antar AM. Metabolic dysregulation in the Atp7b-/- Wilson's disease mouse model. Proc Natl Acad Sci U S A. 2020 01 28; 117(4):2076-2083. PMID: 31924743; PMCID: PMC6994990.
      Citations: 35     Fields:    Translation:HumansAnimals
    2. Jiang X, Zhang C, Chen J, Choi S, Zhou Y, Zhao M, Song X, Chen X, Maletic-Savatic M, Palzkill T, Moore D, Wang MC, Wang J. Quantitative Real-Time Imaging of Glutathione with Subcellular Resolution. Antioxid Redox Signal. 2019 06 01; 30(16):1900-1910. PMID: 30358421; PMCID: PMC6486671.
      Citations: 8     Fields:    Translation:HumansCells
    3. Bayrer JR, Wang H, Nattiv R, Suzawa M, Escusa HS, Fletterick RJ, Klein OD, Moore DD, Ingraham HA. LRH-1 mitigates intestinal inflammatory disease by maintaining epithelial homeostasis and cell survival. Nat Commun. 2018 10 10; 9(1):4055. PMID: 30305617; PMCID: PMC6180039.
      Citations: 24     Fields:    Translation:HumansAnimals
    4. Kettner NM, Voicu H, Finegold MJ, Coarfa C, Sreekumar A, Putluri N, Katchy CA, Lee C, Moore DD, Fu L. Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis. Cancer Cell. 2016 Dec 12; 30(6):909-924. PMID: 27889186; PMCID: PMC5695235.
      Citations: 141     Fields:    Translation:HumansAnimals
    5. White DL, Liu Y, Garcia J, El-Serag HB, Jiao L, Tsavachidis S, Franco LM, Lee JS, Tavakoli-Tabasi S, Moore D, Goldman R, Kuzniarek J, Ramsey DJ, Kanwal F, Marcelli M. Sex hormone pathway gene polymorphisms are associated with risk of advanced hepatitis C-related liver disease in males. Int J Mol Epidemiol Genet. 2014; 5(3):164-76. PMID: 25379136; PMCID: PMC4214264.
      Citations: 7     
    6. Liu Y, El-Serag HB, Jiao L, Lee J, Moore D, Franco LM, Tavakoli-Tabasi S, Tsavachidis S, Kuzniarek J, Ramsey DJ, White DL. WNT signaling pathway gene polymorphisms and risk of hepatic fibrosis and inflammation in HCV-infected patients. PLoS One. 2013; 8(12):e84407. PMID: 24386373; PMCID: PMC3875538.
      Citations: 8     Fields:    Translation:HumansCells
    7. Jiang Y, Iakova P, Jin J, Sullivan E, Sharin V, Hong IH, Anakk S, Mayor A, Darlington G, Finegold M, Moore D, Timchenko NA. Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer. Hepatology. 2013 Mar; 57(3):1098-106. PMID: 23172628; PMCID: PMC3649861.
      Citations: 39     Fields:    Translation:HumansAnimalsCells
    8. Chopra AR, Louet JF, Saha P, An J, Demayo F, Xu J, York B, Karpen S, Finegold M, Moore D, Chan L, Newgard CB, O'Malley BW. Absence of the SRC-2 coactivator results in a glycogenopathy resembling Von Gierke's disease. Science. 2008 Nov 28; 322(5906):1395-9. PMID: 19039140; PMCID: PMC2668604.
      Citations: 96     Fields:    Translation:AnimalsCells
    MOORE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (78)
    Explore
    _
    Co-Authors (17)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _